Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[They were then divided into six categories: (1) the homologous genes which related to the known ovarian cancer genes, such as BARD 1 gene, etc; (2) the homologous genes which were associated with other tumors, such as TM4SFI gene, etc; (3) the genes which were expressed in a special organization, such as ILF3, FXR1 gene, etc; (4) the genes which were the same with some protein genes of special function, such as TIZ, ClD gene; (5) the homologous genes which possessed the same source with embryonic genes, such as PKHD1 gene, etc; (6) the remaining genes were the unknown genes without the homologous sequence in the gene pool, such as OV-189 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP1295318.RAUTEhvO4tq4pG0lauUVFVIOhS9K-zLWpwtJAEnC0j4vA130_assertion description "[They were then divided into six categories: (1) the homologous genes which related to the known ovarian cancer genes, such as BARD 1 gene, etc; (2) the homologous genes which were associated with other tumors, such as TM4SFI gene, etc; (3) the genes which were expressed in a special organization, such as ILF3, FXR1 gene, etc; (4) the genes which were the same with some protein genes of special function, such as TIZ, ClD gene; (5) the homologous genes which possessed the same source with embryonic genes, such as PKHD1 gene, etc; (6) the remaining genes were the unknown genes without the homologous sequence in the gene pool, such as OV-189 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295318.RAUTEhvO4tq4pG0lauUVFVIOhS9K-zLWpwtJAEnC0j4vA130_provenance.
• NP1295319.RAVaH0r3qChaXoWbVhw32szF5KifDOFhRCPpTj_fAg3ew130_assertion description "[They were then divided into six categories: (1) the homologous genes which related to the known ovarian cancer genes, such as BARD 1 gene, etc; (2) the homologous genes which were associated with other tumors, such as TM4SFI gene, etc; (3) the genes which were expressed in a special organization, such as ILF3, FXR1 gene, etc; (4) the genes which were the same with some protein genes of special function, such as TIZ, ClD gene; (5) the homologous genes which possessed the same source with embryonic genes, such as PKHD1 gene, etc; (6) the remaining genes were the unknown genes without the homologous sequence in the gene pool, such as OV-189 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295319.RAVaH0r3qChaXoWbVhw32szF5KifDOFhRCPpTj_fAg3ew130_provenance.
• NP1295321.RAcRP3e_BkIwYwUFEP5s4JdzmnO3ZrHwvXiiimq66QCIw130_assertion description "[They were then divided into six categories: (1) the homologous genes which related to the known ovarian cancer genes, such as BARD 1 gene, etc; (2) the homologous genes which were associated with other tumors, such as TM4SFI gene, etc; (3) the genes which were expressed in a special organization, such as ILF3, FXR1 gene, etc; (4) the genes which were the same with some protein genes of special function, such as TIZ, ClD gene; (5) the homologous genes which possessed the same source with embryonic genes, such as PKHD1 gene, etc; (6) the remaining genes were the unknown genes without the homologous sequence in the gene pool, such as OV-189 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295321.RAcRP3e_BkIwYwUFEP5s4JdzmnO3ZrHwvXiiimq66QCIw130_provenance.
• NP1295315.RAH-fodRHvPJcfbLyEbD_xTbbwOEuMbDPTLQnZnt_4qt0130_assertion description "[They were then divided into six categories: (1) the homologous genes which related to the known ovarian cancer genes, such as BARD 1 gene, etc; (2) the homologous genes which were associated with other tumors, such as TM4SFI gene, etc; (3) the genes which were expressed in a special organization, such as ILF3, FXR1 gene, etc; (4) the genes which were the same with some protein genes of special function, such as TIZ, ClD gene; (5) the homologous genes which possessed the same source with embryonic genes, such as PKHD1 gene, etc; (6) the remaining genes were the unknown genes without the homologous sequence in the gene pool, such as OV-189 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295315.RAH-fodRHvPJcfbLyEbD_xTbbwOEuMbDPTLQnZnt_4qt0130_provenance.
• NP1295316.RAFAfq9S3cYBaJP3s1YVnmYtxS7ys7USSzyyBs2DFowsk130_assertion description "[They were then divided into six categories: (1) the homologous genes which related to the known ovarian cancer genes, such as BARD 1 gene, etc; (2) the homologous genes which were associated with other tumors, such as TM4SFI gene, etc; (3) the genes which were expressed in a special organization, such as ILF3, FXR1 gene, etc; (4) the genes which were the same with some protein genes of special function, such as TIZ, ClD gene; (5) the homologous genes which possessed the same source with embryonic genes, such as PKHD1 gene, etc; (6) the remaining genes were the unknown genes without the homologous sequence in the gene pool, such as OV-189 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295316.RAFAfq9S3cYBaJP3s1YVnmYtxS7ys7USSzyyBs2DFowsk130_provenance.
• NP1295322.RAIa6mEO1Yn1_ZpMsgIPPALEFK125-LjbY1Z0yV7kpQO4130_assertion description "[They were then divided into six categories: (1) the homologous genes which related to the known ovarian cancer genes, such as BARD 1 gene, etc; (2) the homologous genes which were associated with other tumors, such as TM4SFI gene, etc; (3) the genes which were expressed in a special organization, such as ILF3, FXR1 gene, etc; (4) the genes which were the same with some protein genes of special function, such as TIZ, ClD gene; (5) the homologous genes which possessed the same source with embryonic genes, such as PKHD1 gene, etc; (6) the remaining genes were the unknown genes without the homologous sequence in the gene pool, such as OV-189 genes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295322.RAIa6mEO1Yn1_ZpMsgIPPALEFK125-LjbY1Z0yV7kpQO4130_provenance.